
|Videos|October 6, 2017
What Are the Results of the REVIVE-2 Trial?
Author(s)Contagion® Editorial Staff
David Huang, PhD, MD, shares the recent results of the REVIVE-2 trial.
Advertisement
David Huang, PhD, MD, chief medical officer at Motif Bio, shares the recent results of the REVIVE-2 trial.
Newsletter
Stay ahead of emerging infectious disease threats with expert insights and breaking research. Subscribe now to get updates delivered straight to your inbox.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Contagion Live
1
CDC ACIP Workgroup Reviewing FDA-Approved HPV Vaccines
2
Congress Preserves Domestic HIV Funding in Final FY2026 Spending Deal
3
Fedora Pharmaceuticals Highlights First-in-Class Antibiotic at Conference
4
FDA Clears First At-Home Diagnostic for RSV, Influenza, and COVID-19 in Adults, Young Infants
5































































































































